RE: new article I really enjoyed reading this bit:
"He says the company plans to follow the same regulatory pathway as Aura for the Core, gaining approvals in Canada and Europe, and launching the device in non-U.S. markets in 2014.
The company also is in the process of expanding the indications for Core. Mr. Braun says the BC Cancer Agency has received grant funding to start a colon cancer study this year using the Core technology at Vancouver General Hospital. In Asia, a pilot study has been done in Singapore on esophageal cancer, and in China, a study will start this year on nasopharyngeal cancer.
“What this means is that every couple years, we have the potential to launch a new product, and with these new products, we have the potential to be selling 100 units per quarter,” Mr. Braun suggests."